COST ANALYSIS OF STROKE CASES ADMITTED TO OUR EMERGENCY DEPARTMENT IN TÜRKIYE
Objective: It was aimed to investigate and costs of stroke patients.
Materials and methods: A database of stroke patients admitted between November 15th, 2016, and November 15th, 2017.was constructed. Descriptive statistics were used to summarize cost and patients’ demographics. Mann-Witney U test was used in the analysis of nonparametric data. A value of p<0.05 was considered statistically significant
Results: A total of 91 patients were analyzed, the median age was 79 (12) years.
The median cost for ischemic stroke patients included in our study was $573.78 [$1307.75], while for hemorrhagic stroke patients, it was $1161.69 [$2128]. We found a statistically significant difference in costs between stroke types (p<0.05). The cost of hemorrhagic stroke to our hospital was higher.
Conclusions: According to our study, we found that the median cost of patients was $859.66. We also observed that gender and comorbidities did not affect the cost.
Serhat İldes1, Cemil Kavalci2, Kaan Celik1,
Beliz Oztok Tekten1, Gülsüm Kavalci3
1 Abant Izzet Baysal University Faculty of Medicine, Emergency Medicine Department, Bolu, Türkiye;
2 Health Science University of Türkiye, Antalya Training and Research Hospital,
Emergency Departmeny, Türkiye;
3 University of Health Science Turkey, Antalya Training and Research Hospital,
Anesthesiology Department, Türkiye.
1. Bergman L., van der Meulen J.H., Limburg M., Habbema J.D. Costs of medical care after first-ever stroke in the Netherlands // Stroke, 1995. 26(10):1830-1836.
2. Caro J.J., Huybrechts K.F., Kelley H.E. Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction // Stroke, 2001. 32(1):100-106.
3. Chang K.C., Tseng M.C., Weng H.H., Lin Y.H., Liou C.W., Tan T.Y. Prediction of length of stay of first-ever ischemic stroke // Stroke, 2002. 33(11):2670-2674.
4. Christensen M.C., Valiente R., Silva S.G., Lee W.C., Dutcher S., Rocha M.S.G., et al. Acute treatment costs of stroke in Brazil // Neuroepidemiology. 2009, 32:142–149.
5. Çığşar G., User N.N. Analysis of Acute Stroke Patients Admitted to the Emergency Department // Kafkas J Med Sci, 2015. 5(1): 6-12.
6. Demaerschalk B.M., Hwang H.M., Leung G. US cost burden of ischemic stroke: a systematic literature review // Am J Manag Care, 2010;16(7):525-533.
7. Diesto J.D.B., Omar A.T., Sarmiento R.J.C., Enriquez C.A.G., Chua-DeCastillo L.L., Ho B.L. Cost of hospitalization for stroke in a low-middle-income country: Findings from a public tertiary hospital in the Philippines // Int J Stroke. 2021;16(1):39-42. doi: 10.1177/1747493020906872.
8. Diringer M., Edwards D.F., Mattson D.T., Akins P.T., Sheedy C.W., Hsu C.Y., Dromerick A.W. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center // Stroke, 1999. 30(4):724-728.
9. Evers S.M., Ament A.J., Blaauw G. Economic evaluation in stroke research: a systematic review // Stroke, 2000;31(5):1046-1053.
10. Evers S.M., Goossens M.E., Ament A.J., Maarse J.A. Economic evaluation in stroke research. An introduction // Cerebrovascular diseases (Basel, Switzerland), 2001. 11(2):82-91.
11. Fagan S.C., Morgenstern L.B., Petitta A., Ward R.E., Tilley B.C., Marler J.R. et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group // Neurology, 1998. 50(4):883-90.
12. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.L., Berry J.D., Borden W.B. et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association // Circulation, 2013. 127(1):6-245.
13. Gustavsson A., Svensson M., Jacobi F., Allgulander C., Alonso J., Beghi E., et al. Cost of disorders of the brain in Europe 2010 // Eur Neuropsychopharmacol, 2011. 21(10):718-779.
14. Holloway R., Witter Jr.D., Lawton K.B., Lipscomb J., Samsa G. Inpatient costs of specific cerebrovascular events at five academic medical centers // Neurology, 1996. 46(3):854-860.
15. İçağasıoğlu A., Baklacıoğlu H.Ş., Mesci E., Yumuşakhuylu Y., Murat S., Mesci N. Economic burden of stroke // Turk J Phys Med Rehabil, 2017. 63(2):155-159.
16. Jorgensen H., Nakayama H., Reith J., Raaschou H.O., Olsen T.S. Factors delaying hospital admission in acute stroke The Copenhagen Stroke Study // Neurology, 1996. 47(2):383-387
17. Kandemir M., Kalyoncu-Aslan I., Bakaç G., Kırbaş D. Cost Evaluation in Acute Stroke // Archives of Neuropsychiatry, 2012. 49(3):72-177.
18. Kwatra G., Kaur P., Toor G., Badyal D.K., Kaur R., Singh Y., Pandian J.D. Cost of stroke from a tertiary center in northwest India // Neurol India. 2013, 61: 627.
19. Lorenzovici L., Székely A., Csanádi M., Gaál P. Cost Assessment of Inpatient Care Episodes of Stroke in Romania // Front. Public Health 2020. 8:605919. doi: 10.3389/fpubh.2020.605919
20. Ng C.S., Toh M.P., Ng J., Ko Y. Direct medical cost of stroke in Singapore // Int J Stroke 2015. 10: 75–82
21. Nordin N.A.M., Aljunid S.M., Aziz N.A., Nur M. Sulong S. Direct medical cost of stroke: findings from a tertiary hospital in Malaysia // Med J Malaysia, 2012. 67: 472–477
22. Nguyen T., Le T. Inpatient treatment cost of post-stroke: an analysis in hospital of Occupational Diseases and Rehabilitation, Vietnam // Value Heal. 2016, 19:A649
23. Pan Y., Chen O., Zhao X., Liao X., Wang C., Du W., et al., Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China // PloS one, 2014. 9(10):1-8.
24. Persson J., Ferraz-Nunes J., Karlberg I. Economic burden of stroke in a large county in Sweden // BMC health services research, 2012. 12(341):1-8.
25. Rha J.H., Koo J., Cho K.H., Kim E.G., Oh G.S. et al. Two-year direct medical costs of stroke in Korea: a multi-centre incidence-based study from hospital perspectives // International Journal of Stroke 2012. doi:10. .1111/j.1747-4949.2012.00815.x
26. Reed S.D., Blough D.K., Meyer K., Jarvik J.G. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals // Neurology, 2001. 57(2):305-314.
27. Smurawska L.T., Alexandrov A.V., Bladin C.F., Norris J.W. Cost of Acute Stroke Care in Toronto, Canada // Stroke 1994. 25(8):1628-1631
28. Tanny S.P., Busija L., Liew D., Teo S., Davis S.M., Yan B. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
29. Taylor T.N., Davis P.H., Torner J.C., Holmes J., Meyer J.W., Jacobsonet M.F. Lifetime cost of stroke in the United States // Stroke, 1996. 7(9):1459-1466.
30. van Eeden M., van Heugten C.M., Evers S.M. The economic impact of stroke in The Netherlands: the €-restore4stroke study // BMC Public Health, 2012. 12(1):122.
31. Wang G., Zhang Z., Ayala C., Dunet D., Fang J., George M. Costs of hospitalization for stroke patients aged 18–64 years in the United States. J Stroke Cerebrovasc Dis 2014; 23: 861–868
32. Yin X., Huang L., Man X., Jiang Y., Zhao X., Zhao L., Cheng W. Inpatient cost of stroke in Beijing: a descriptive analysis // Neuroepidemiology. 2018, 51: 115–122
33. Yoneda Y., Okuda S., Hamada R., Toyota A., Gotoh J., Watanabe M., et al. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers // Health Policy (New York). 2005. 73: 202–211
34. Yoneda Y., Uehara T., Yamasaki H., Kita Y., Tabuchi M., Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan // Stroke, 2003. 34(3): p. 718-724
35. Zhao Y., Condon J., Lawton P., He V., Cadilhac D.A. Lifetime direct costs of stroke for indigenous patients adjusted for comorbidities // Neurology 2016. 87. 458-465
Number of Views: 89
Category of articles:
Original articles
Bibliography link
Ildes S., Kavalci C., Celik K., Tekten B.0., Kavalci G. Cost Analysis of Stroke Cases Admitted to Our Emergency Department in Türkiye // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 2, pp. 35-40. doi 10.34689/SH.2023.25.2.005Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS